CNS Prophylaxis in Diffuse Large B-cell Lymphoma

NCT02777736 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG: Methotrexate

Sponsor

Czech Lymphoma Study Group